CULLINAN THERAPEUTICS
15.58
07-November-24 15:59:58
15 minutes delayed
Stocks
-0.90
-5.46%
Today's range
15.37 - 17.19
ISIN
N/A
Source
NASDAQ
-
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Jan 2023 17:13:42 By Nasdaq GlobeNewswire
-
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Dec 2022 17:00:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2022 Financial Results
14 Nov 2022 07:00:03 By Nasdaq GlobeNewswire
-
Cullinan Oncology Announces the Appointment of David P. Ryan, M.D. to its Board of Directors
02 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Nov 2022 17:23:46 By Nasdaq GlobeNewswire
-
Cullinan Oncology to Participate in Upcoming Investor Conferences
01 Nov 2022 07:00:01 By Nasdaq GlobeNewswire
-
25 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Oct 2022 16:50:00 By Nasdaq GlobeNewswire
-
07 Sep 2022 08:00:02 By Nasdaq GlobeNewswire
-
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Sep 2022 17:27:22 By Nasdaq GlobeNewswire
-
Cullinan Oncology Announces Appointment of Jacquelyn Sumer as Chief Legal Officer
15 Aug 2022 16:57:42 By Nasdaq GlobeNewswire
-
Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2022 Financial Results
10 Aug 2022 07:00:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Aug 2022 16:55:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology to Participate in William Blair Biotech Focus Conference
05 Jul 2022 16:01:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Jul 2022 16:38:19 By Nasdaq GlobeNewswire
-
23 Jun 2022 08:00:01 By Nasdaq GlobeNewswire
-
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Jun 2022 17:00:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology to Host Analyst and Investor Briefing at 2022 ASCO Annual Meeting
26 May 2022 08:45:00 By Nasdaq GlobeNewswire